<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >While&nbsp;a&nbsp;vaginal&nbsp;discharge&nbsp;is&nbsp;a&nbsp;notable clinical&nbsp;feature&nbsp;of&nbsp;an&nbsp;STI,&nbsp;not&nbsp;all forms of vaginal discharge are abnormal or indicative of an STI. A vaginal discharge may be associated with a physiological state such as menses or pregnancy, or with the presence or use of foreign substances and chemicals in the&nbsp;vagina.</span></p><p style="text-align:justify;"><span >A careful risk assessment (See note below) of women with a&nbsp; vaginal discharge may help identify STIs and non-STIs and selection of appropriate treatment&nbsp;regimens&nbsp;based on&nbsp;the&nbsp;most&nbsp;likely&nbsp;aetiology of&nbsp;the vaginal discharge. 0ther considerations for selecting treatment include pregnancy status and patient&nbsp;discomfort.</span></p><h3>CAUSES</h3><p>•&nbsp; <i>Neisseria&nbsp;gonorrhoea</i></p><p>•&nbsp; <i>Chlamydia&nbsp;trachomatis</i></p><p>•&nbsp; <i>Trichomonas vaginalis&nbsp;</i>(green or yellow, smelly,&nbsp;bubbly or frothy discharge associated with&nbsp;itching)</p><p>•&nbsp; Herpes&nbsp;simplex virus&nbsp;(following&nbsp;first episode&nbsp;of&nbsp;infection)</p><h3>SYMPTOMS</h3><p>•&nbsp; Vaginal&nbsp;discharge-&nbsp;change&nbsp;in&nbsp;colour,&nbsp;odour,&nbsp;consistency&nbsp;or&nbsp;amount</p><p>•&nbsp; Vulval&nbsp;swelling</p><p>•&nbsp; Pain on&nbsp;urination</p><p>•&nbsp; Lower abdominal or back&nbsp;pain</p><h3>SIGNS</h3><p>•&nbsp; Vaginal&nbsp;discharge</p><p>•&nbsp; Vulval&nbsp;swelling</p><p>•&nbsp; Vulval&nbsp;erythema</p><p>•&nbsp; Lower abdominal&nbsp;tenderness</p><p>•&nbsp; Cervical excitation&nbsp;tenderness</p><p>•&nbsp; Cervical mucopus or erosions (on speculum&nbsp;examination)</p><h3>INVESTIGATIONS</h3><p>•&nbsp; High&nbsp;vaginal swab&nbsp;for&nbsp;microscopy,&nbsp;culture&nbsp;and&nbsp;sensitivity&nbsp;(if&nbsp;available)</p><h3>TREATMENT</h3><h3><strong>Treatment objectives</strong></h3><p>•&nbsp; To&nbsp;identify&nbsp;and&nbsp;treat non-STI&nbsp;vaginitis&nbsp;(especially&nbsp;candidiasis,&nbsp;which&nbsp;is frequently&nbsp;diagnosed&nbsp;in&nbsp;women being&nbsp;evaluated&nbsp;for&nbsp;STIs)</p><p>•&nbsp; To&nbsp;assess&nbsp;STI&nbsp;risk&nbsp;and&nbsp;treat&nbsp;STI-related&nbsp;infections&nbsp;appropriately</p><p>•&nbsp; To&nbsp;prevent complications and&nbsp;sequelae</p><p>•&nbsp; To&nbsp;treat both partners simultaneously as much as&nbsp;possible</p><h3>Non-pharmacological treatment</h3><p>•&nbsp; None for STI-related&nbsp;discharge</p><h3>Pharmacological Treatment<br><span >Evidence Rating: [C]</span></h3><h3><span >A. Treatment for trichomoniasis and bacterial&nbsp;vaginosis</span></h3><p>•&nbsp; Metronidazole,&nbsp;oral,&nbsp;2&nbsp;g&nbsp;stat.&nbsp;(contraindicated&nbsp;during&nbsp;the&nbsp;1st&nbsp;trimester of&nbsp;pregnancy)</p><h3>Or</h3><p>•&nbsp; Metronidazole, oral, 400 mg 8 hourly for 5 days (contraindicated during the 1st trimester of pregnancy)</p><h3>Or</h3><p>•&nbsp; Secnidazole,&nbsp;oral,&nbsp;2&nbsp;g&nbsp;stat.(contraindicated&nbsp;during&nbsp;the&nbsp;1st&nbsp;trimester of&nbsp;pregnancy)</p><h3>Or</h3><p>•&nbsp; Tinidazole,&nbsp;oral,&nbsp;2&nbsp;g&nbsp;stat.(contraindicated&nbsp;during&nbsp;the&nbsp;1st&nbsp;trimester&nbsp;of pregnancy)</p><h3>Or</h3><p>•&nbsp; Clindamycin&nbsp;cream&nbsp;(2%),&nbsp;topical(preferred&nbsp;in&nbsp;pregnancy)</p><h3>And</h3><p><span ><strong>B. Treatment for&nbsp;candidiasis</strong></span></p><p>•&nbsp; Miconazole&nbsp;vaginal&nbsp;tablets, 200&nbsp;mg&nbsp;inserted&nbsp;into&nbsp;vagina at&nbsp;night&nbsp;for&nbsp;3&nbsp;days</p><p><strong>Or</strong></p><p>•&nbsp; Clotrimazole,&nbsp;vaginal&nbsp;tablets,200&nbsp;mg&nbsp;inserted&nbsp;into&nbsp;vagina&nbsp;at&nbsp;night for 3&nbsp;days</p><p><strong>And</strong></p><p>•&nbsp; Clotrimazole&nbsp;cream, apply&nbsp;12&nbsp;hourly&nbsp;(for&nbsp;vulval irritation)</p><h3><span >C. Treatment for&nbsp;gonorrhoea</span></h3><p>•&nbsp; Ceftriaxone, IM, 250 mg&nbsp;stat.</p><h3>Or</h3><p>•&nbsp; Cefixime, oral, 400 mg&nbsp;stat</p><h3>Or</h3><p>•&nbsp; Ciprofloxacin, oral, 500 mg stat. (avoid in pregnant and lactating mothers)</p><h3>And</h3><p><span ><strong>D. Treatment for&nbsp;chlamydia</strong></span></p><p>•&nbsp; Doxycycline,&nbsp;oral,&nbsp;100&nbsp;mg&nbsp;12&nbsp;hourly&nbsp;for&nbsp;7&nbsp;days&nbsp;(avoid&nbsp;in&nbsp;pregnant&nbsp;and lactating&nbsp;mothers)</p><h3>Or</h3><p>•&nbsp; Tetracycline,&nbsp;oral,&nbsp;500&nbsp;mg&nbsp;6&nbsp;hourly&nbsp;for&nbsp;7&nbsp;days(avoid&nbsp;in&nbsp;pregnant&nbsp;and lactating&nbsp;mothers)</p><h3>Or</h3><p>•&nbsp; Erythromycin,&nbsp;oral,500&nbsp;mg&nbsp;6&nbsp;hourly&nbsp;for&nbsp;7&nbsp;days</p><h3>Or</h3><p>•&nbsp; Azithromycin, oral, 2 g&nbsp;stat.</p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span >Refer all cases of recurrent vaginal discharge and/or treatment failures to a health facility where speculum examination can be carried out and microbiological culture and antimicrobial sensitivity tests can be done on the vaginal discharge.</span></p>
</body>
</html>
